What question did this study set out to answer?

This article aims to provide a framework for individualized management of immune checkpoint inhibitor myocarditis in adults.

November 17, 2025Cardio-OncologyOpen Access

How should immune checkpoint inhibitor myocarditis be treated?

View Full Paper

Ask AI

Bookmark

Authors

SBSally Badaan AAAdi Abbass STSvetlana Tov

Discussion

Member takes

Implication

Clinical observations highlight a personalized approach to treating myocarditis in cancer therapy, suggesting immunomodulators like abatacept may improve outcomes.

Key Points

This article aims to provide a framework for individualized management of immune checkpoint inhibitor myocarditis in adults.
Review of clinical presentations and treatment guidelines for immune checkpoint inhibitor-related myocarditis.
Analysis of diagnostic frameworks including echocardiography and endomyocardial biopsy.
Discussion of treatment options including corticosteroids and immunomodulators.
Corticosteroids are the cornerstone of therapy, reducing major adverse cardiovascular events.
Immunomodulators like mycophenolate mofetil and abatacept may be beneficial in severe cases.
Echocardiography and endomyocardial biopsy play critical roles in diagnosis and management.

Cite This Study

Badaan et al. (2025) studied this question.

synapsesocial.com/papers/692509e3c0ce034ddc352600 https://doi.org/10.1186/s40959-025-00404-8

View Full Paper

Ask AI

Bookmark

Implication

Clinical observations highlight a personalized approach to treating myocarditis in cancer therapy, suggesting immunomodulators like abatacept may improve outcomes.

How should immune checkpoint inhibitor myocarditis be treated?

Discussion

Member takes

Implication

Key Points

Cite This Study

How should immune checkpoint inhibitor myocarditis be treated?

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider